Home | About RECERCAT | Contact
Català | Castellano

All of RECERCAT

By Communities &
Collections By Defense Date By Authors By Titles By Subject

This Collection

By Defense Date By Authors By Titles By Subject 

Statistics

View Statistics All RECERCAT

My RECERCAT

Login E-mail Alerts
Other repositories directory 
RECERCAT Home > Universitat Autònoma de Barcelona > Articles escrits per personal UAB o publicats per la universitat > View document
dc.contributor.author Thaçi, Diamant
dc.contributor.author Puig Sanz, Lluís.
dc.contributor.author Reich, K.
dc.contributor.author Tsai, T. F.
dc.contributor.author Tyring, S.
dc.contributor.author Kingo, K.
dc.contributor.author Ziv, M.
dc.contributor.author Pinter, A.
dc.contributor.author Vender, R.
dc.contributor.author Lacombe, A.
dc.contributor.author Xia, Shang
dc.contributor.author Bhosekar, V.
dc.contributor.author Gilloteau, I.
dc.contributor.author Guana, A.
dc.contributor.author Blauvelt, Andrew
dc.contributor.author Universitat Autònoma de Barcelona
dc.date 2019
dc.identifier https://ddd.uab.cat/record/222744
dc.identifier urn:10.1016/j.jaad.2019.04.045
dc.identifier urn:oai:ddd.uab.cat:222744
dc.identifier urn:scopus_id:85074743708
dc.identifier urn:articleid:10976787v81n6p1405
dc.identifier urn:pmid:31399223
dc.format application/pdf
dc.language eng
dc.publisher
dc.relation Journal of the American Academy of Dermatology ; Vol. 81 Núm. 6 (december 2019), p. 1405-1409
dc.rights open access
dc.rights Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, i la comunicació pública de l'obra, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original. No es permet la creació d'obres derivades.
dc.rights https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.title Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment : Results from the CLEAR study
dc.type Article
dc.description.abstract

Show simple item record

Related documents

Other documents of the same author

Long-term efficacy and safety of tildrakizumab for moderate-to-severe psoriasis : pooled analyses of two randomized phase clinical trials (re 1 and re 2) through 148 weeks
Reich, K.; Warren, R. B.; Iversen, Lars; Puig Sanz, Lluís.; Pau-Charles, I.; Igarashi, A.; Ohtsuki, M.; Falqués, M.; Harmut, M.; Rozzo, S.; Lebwohl, M. G.; Cantrell, W.; Blauvelt, Andrew; Thaçi, Diamant; Universitat Autònoma de Barcelona
Complete clearance and Psoriasis Area and Severity Index response for brodalumab and ustekinumab by previous treatment history in AMAGINE-2 and AMAGINE-3
Reich, K.; Hansen, Jes Birger; Puig Sanz, Lluís; Konstantinou, M.P.; Warren, R. B.; Universitat Autònoma de Barcelona
Complete clearance and psoriasis area and severity index response for brodalumab and ustekinumab in AMAGINE-2 and -3
Warren, R. B.; Hansen, Jes Birger; Reich, K.; Paul, C.; Puig Sanz, Lluís; Universitat Autònoma de Barcelona
Correction to : Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Blauvelt, Andrew; Papp, Kim A.; Griffiths, Christopher E. M.; Puig Sanz, Lluís; Weisman, Jamie; Dutronc, Yves; Kerr, Lisa Farmer; Ilo, Dapo; Mallbris, Lotus; Augustin, Matthias; Universitat Autònoma de Barcelona
Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis : A Model-Based Meta-Analysis
Checchio, T.; Ahadieh, S.; Gupta, P.; Mandema, J.; Puig Sanz, Lluís.; Wolk, R.; Valdez, H.; Tan, H.; Krishnaswami, S.; Tallman, A.; Kaur, M.; Ito, K.; Universitat Autònoma de Barcelona
Accesibility | Legal note | Cookies Policy
 

Coordination

 

Supporters